Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Fleckenstein

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2004
Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institutionKatharina Fleckenstein, Holger Hof, Frank Lohr, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 11, 2003
Irradiation for conjunctival granulocytic sarcomaKatharina Fleckenstein, Hans Geinitz, Anca Grosu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 4, 2004
[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part II: radiobiological and immunologic strategies]Carsten Herskind, Katharina Fleckenstein, Jens Lohr, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 2, 2004
[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis]Carsten Herskind, Katharina Fleckenstein, Jens Lohr, et al.
Seminars in Radiation Oncology|March 31, 2007
Using biological markers to predict risk of radiation injuryKatharina Fleckenstein, Benjamin Gauter-Fleckenstein, Isabel L Jackson, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 25, 2008
Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumorsGrit Welzel, Katharina Fleckenstein, Sabine K Mai, et al.
Free Radical Biology & Medicine|December 18, 2007
Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotectionBenjamin Gauter-Fleckenstein, Katharina Fleckenstein, Kouros Owzar, et al.
Onkologie|April 15, 2010
Bone marrow-sparing intensity-modulated radiotherapy (IMRT) for neo-adjuvant therapy of inoperable cervical cancer in a patient with severe thrombocytopeniaAnna Simeonova, Yasser Abo-Madyan, Philipp Ströbel, et al.
International Journal of Radiation Oncology, Biology, Physics|May 2, 2008
Memory function before and after whole brain radiotherapy in patients with and without brain metastasesGrit Welzel, Katharina Fleckenstein, Jörg Schaefer, et al.
Translational Lung Cancer Research|March 26, 2015
Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?Anna O Simeonova, Katharina Fleckenstein, Hansjörg Wertz, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2004
Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institutionKatharina Fleckenstein, Holger Hof, Frank Lohr, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 11, 2003
Irradiation for conjunctival granulocytic sarcomaKatharina Fleckenstein, Hans Geinitz, Anca Grosu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 4, 2004
[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part II: radiobiological and immunologic strategies]Carsten Herskind, Katharina Fleckenstein, Jens Lohr, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 2, 2004
[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis]Carsten Herskind, Katharina Fleckenstein, Jens Lohr, et al.
Seminars in Radiation Oncology|March 31, 2007
Using biological markers to predict risk of radiation injuryKatharina Fleckenstein, Benjamin Gauter-Fleckenstein, Isabel L Jackson, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 25, 2008
Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumorsGrit Welzel, Katharina Fleckenstein, Sabine K Mai, et al.
Free Radical Biology & Medicine|December 18, 2007
Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotectionBenjamin Gauter-Fleckenstein, Katharina Fleckenstein, Kouros Owzar, et al.
Onkologie|April 15, 2010
Bone marrow-sparing intensity-modulated radiotherapy (IMRT) for neo-adjuvant therapy of inoperable cervical cancer in a patient with severe thrombocytopeniaAnna Simeonova, Yasser Abo-Madyan, Philipp Ströbel, et al.
International Journal of Radiation Oncology, Biology, Physics|May 2, 2008
Memory function before and after whole brain radiotherapy in patients with and without brain metastasesGrit Welzel, Katharina Fleckenstein, Jörg Schaefer, et al.
Translational Lung Cancer Research|March 26, 2015
Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?Anna O Simeonova, Katharina Fleckenstein, Hansjörg Wertz, et al.
Pageof 2